Clinical Trial Update: Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

View source ↗

Summary

A clinical trial is recruiting to study alpha-synuclein RT-QuIC and neurologic symptoms in people with idiopathic anosmia and related olfactory dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Anosmia
• Idiopathic Hyposmia
• Idiopathic Olfactory Dysfunction

Snippet

Sponsor: Danish Dementia Research Centre | Conditions: Idiopathic Anosmia, Idiopathic Hyposmia | Status: RECRUITING